Custom service

Codon Optimization

The sequence before the sequence — where expression yield is decided.

Hosts: E. coli (per strain), CHO, HEK293, Sf9, Pichia, S. cerevisiae, plantChecks: CAI, GC content, mRNA structure, splice sites, instability motifs, restriction sitesTimeline: 3–5 days per sequence

Codon optimisation is routinely reduced to matching codon usage tables, which is why it routinely disappoints. The codon a host prefers matters, but expression is decided by more than that: mRNA secondary structure around the start codon, ribosome pausing sites, cryptic splice sites in mammalian cells, RNA instability motifs, internal TATA boxes, and — for secreted proteins — the interaction of codon usage with the signal peptide's translation kinetics.

Optimisation is a constraint-satisfaction problem, not a substitution problem. The protein sequence is fixed; the coding choices must satisfy the host's codon preferences, avoid the motifs that damage expression, preserve any regulatory features the construct depends on, and — where a rare codon deliberately slows translation to let a domain fold — preserve that pause rather than smooth it away. Optimising everything to maximum speed can hurt proteins whose folding depends on co-translational timing.

The deliverable is a sequence with its reasoning. Codon adaptation index, predicted mRNA structures, avoided motifs and the deliberate pauses are documented, and the sequence is verified by synthesis and expression where the project continues into production. When two plausible designs exist, both are synthesised in small scale — the difference between them is measured, not argued.

Codon optimisation matters most for heterologous expression of proteins from GC-rich or AT-rich genomes, for high-yield production, and for mammalian constructs carrying cryptic splice sites that fragment the transcript.

It is a low-value investment for a protein that already expresses acceptably, and it cannot rescue a construct whose problem is the protein itself — insolubility and misfolding are protein properties, not codon properties.

Every optimised sequence is verified against the protein sequence it encodes, checked for the screened motifs, and delivered with the design rationale. Where an A/B comparison was run, both sequences' expression data are included and the choice is documented by measurement.

Service Highlights

  • Host-specific tables. Codon usage from measured host data — E. coli strain, CHO, HEK293, insect, Pichia, plant — not generic tables.
  • Start-codon structure control. MRNA secondary structure around the initiation region modelled and avoided or preserved deliberately.
  • Motif screening. Cryptic splice sites, polyadenylation signals, RNA instability motifs and internal promoters screened and removed.
  • Translational pauses preserved. Rare codons that pace domain folding retained where the protein's folding requires them.
  • Signal peptide aware. Codon choices checked against the signal peptide's translation kinetics for secreted targets.
  • A/B design comparison. Where the optimal design is ambiguous, two variants are synthesised and compared empirically.

How the work runs

  1. Host and context review

    Expression host, vector, promoter and protein class reviewed, since all four change what the sequence should look like.

  2. Sequence optimisation

    Codon choices optimised with motif screening and structure modelling applied simultaneously.

  3. Constraint check

    Protein sequence integrity confirmed; deliberate pauses and regulatory features preserved or deliberately removed.

  4. Alternative design

    Where the design space is ambiguous, a second sequence generated for comparison.

  5. Verification

    Synthesis and sequence confirmation; small-scale expression comparison where the project continues.

  6. Delivery

    Optimised sequence, design report and, where expressed, the comparison data.

Specifications & timeline

Hosts
E. coli (per strain), CHO, HEK293, Sf9, Pichia, S. cerevisiae, plant
Checks
CAI, GC content, mRNA structure, splice sites, instability motifs, restriction sites
Timeline
3–5 days per sequence
Output
Optimised coding sequence, design report, optional A/B expression comparison
Compatibility
Delivered as GeneArt/IDT-compatible or synthesised directly

Related Products

Next step

Tell us the target, we will tell you what is feasible

Send the sequence, assay format and sensitivity you need. You will get a technical assessment — recommended platform, timeline and the risks worth knowing before you commit budget.